Skip to content

Little difference in child transmission rates between formula feed and breast-plus-AZT

Two new drug classes given to people with HIV for the first time

Pregnant women with CD4 cell counts over 250 not at greater risk of nevirapine-related toxicity in Kenyan study

Therapeutic range for atazanavir defined

Highly sensitive method uncovers high levels of resistance in mothers given single-dose nevirapine

Addition of capravirine to a three-drug regimen not beneficial in patients with NNRTI resistance

Long-term CD4 increase on HAART averages 250-350 cells, plateaus after 3-4 years

The ‘New York case’: details revealed at Boston conference

Switch to tenofovir better than change to abacavir?